MorphoSys AG is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapies for people living with cancer and autoimmune diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Jean-Paul Kress$2.7B
Market Cap • 19/04/20241992
(há 32 anos)
2018
(6 years ago)
NASDAQ
Listagem
Planegg
Sede • BY629
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
MORSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.